Invention Grant
- Patent Title: Methods for treating Parkinson's disease
- Patent Title (中): 治疗帕金森病的方法
-
Application No.: US14395533Application Date: 2013-04-19
-
Publication No.: US09387212B2Publication Date: 2016-07-12
- Inventor: Anne Michel , Patrick Downey , Florian Montel , Dieter Scheller , Bernard Christophe
- Applicant: UCB Pharma S.A.
- Applicant Address: BE Brussels
- Assignee: UCB Biopharma SPRL
- Current Assignee: UCB Biopharma SPRL
- Current Assignee Address: BE Brussels
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- International Application: PCT/EP2013/058212 WO 20130419
- International Announcement: WO2013/156614 WO 20131024
- Main IPC: A61K31/5377
- IPC: A61K31/5377 ; A61K31/195 ; A61K31/198 ; A61K31/445 ; A61K31/451 ; A61K31/495 ; A61K31/497 ; A61K31/501 ; A61K31/506 ; A61K31/519 ; A61K31/52 ; A61K31/423 ; A61K31/5415 ; A61K45/06 ; A61K31/454
Abstract:
The invention pertains to a method of treating Parkinson's disease (PD) in a mammal, comprising administering a first pharmaceutical agent and a second pharmaceutical agent, wherein the first pharmaceutical agent is an antagonist of the adenosine receptor 2 (A2A) and the second pharmaceutical agent is an antagonist of the N-methyl-D-aspartate (NMDA) receptor subtype NR2B.
Public/Granted literature
- US20150157638A1 Methods for Treating Parkinson's Disease Public/Granted day:2015-06-11
Information query
IPC分类:
